Matches in Nanopublications for { ?s ?p "[Patients were included either when hypocretin deficiency was documented (CSF hypocretin-1?110 pg/ml, n=91) or on the basis of the presence of clear cataplexy and HLA-DQB1?0602 positivity (n=419).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Patients were included either when hypocretin deficiency was documented (CSF hypocretin-1?110 pg/ml, n=91) or on the basis of the presence of clear cataplexy and HLA-DQB1?0602 positivity (n=419).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP169356.RA4_D97cUD4MpMCy4Tj7ObowqvjtJ7MgrHXTJtQ5OdLdM130_assertion description "[Patients were included either when hypocretin deficiency was documented (CSF hypocretin-1?110 pg/ml, n=91) or on the basis of the presence of clear cataplexy and HLA-DQB1?0602 positivity (n=419).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169356.RA4_D97cUD4MpMCy4Tj7ObowqvjtJ7MgrHXTJtQ5OdLdM130_provenance.
- assertion description "[Patients were included either when hypocretin deficiency was documented (CSF hypocretin-1?110 pg/ml, n=91) or on the basis of the presence of clear cataplexy and HLA-DQB1?0602 positivity (n=419).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP453505.RAZjEfcHyDlH7qnY5eJr0RAWjDGtcfVzS7GVVKTFq99VQ130_assertion description "[Patients were included either when hypocretin deficiency was documented (CSF hypocretin-1?110 pg/ml, n=91) or on the basis of the presence of clear cataplexy and HLA-DQB1?0602 positivity (n=419).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453505.RAZjEfcHyDlH7qnY5eJr0RAWjDGtcfVzS7GVVKTFq99VQ130_provenance.
- NP454073.RAbKt9qFYvRz5_QuCyWXm99gV3sKh-OKfDrEk0i5KbQRI130_assertion description "[Patients were included either when hypocretin deficiency was documented (CSF hypocretin-1?110 pg/ml, n=91) or on the basis of the presence of clear cataplexy and HLA-DQB1?0602 positivity (n=419).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454073.RAbKt9qFYvRz5_QuCyWXm99gV3sKh-OKfDrEk0i5KbQRI130_provenance.
- NP619497.RALs_j1n9qpwxXXfG60MCQuLiDmzD_zAb9LG_ixK6MGBo130_assertion description "[Patients were included either when hypocretin deficiency was documented (CSF hypocretin-1?110 pg/ml, n=91) or on the basis of the presence of clear cataplexy and HLA-DQB1?0602 positivity (n=419).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619497.RALs_j1n9qpwxXXfG60MCQuLiDmzD_zAb9LG_ixK6MGBo130_provenance.
- NP947349.RAX-e_Th-GmK4yhZ9xCSfBR-yhFob80AIRuxUvQhF00pc130_assertion description "[Patients were included either when hypocretin deficiency was documented (CSF hypocretin-1?110 pg/ml, n=91) or on the basis of the presence of clear cataplexy and HLA-DQB1?0602 positivity (n=419).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947349.RAX-e_Th-GmK4yhZ9xCSfBR-yhFob80AIRuxUvQhF00pc130_provenance.
- NP947352.RAU3kJHirWBAL5x-L3xfndClEkt4q1rZYIqGUt9syhfJs130_assertion description "[Patients were included either when hypocretin deficiency was documented (CSF hypocretin-1?110 pg/ml, n=91) or on the basis of the presence of clear cataplexy and HLA-DQB1?0602 positivity (n=419).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947352.RAU3kJHirWBAL5x-L3xfndClEkt4q1rZYIqGUt9syhfJs130_provenance.